Background and purpose: Treatment plan verification of intensity modulated radiotherapy (IMRT) is generally performed with the gamma index (GI) evaluation method, which is difficult to extrapolate to clinical implications. Incorporating Dose Volume Histogram (DVH) information can compensate for this. …

PURPOSE: Advanced radiotherapy treatments require appropriate quality assurance (QA) to verify 3D dose distributions. Moreover, increase in patient numbers demand efficient QA-methods. In this study, a time efficient method that combines model-based QA and measurement-based QA was developed; i.e., the …

The COMPASS system (IBADosimetry) is a quality assurance (QA) tool which reconstructs 3D doses inside a phantom or a patient CT. The dose is predicted according to the RT plan with a correction derived from 2D measurements of a matrix detector. This correction method is necessary since a direct reconstruction …

To validate the model-based 3D dose calculation performed by the COMPASS system, and to evaluate the use of the combination of model-based and measurement-based 3D dose determination for clinical QA purposes.

To quantify the dosimetric accuracy of the COMPASS correction kernel method, and to determine its ability to detect dose delivery errors caused by MLC leaf mis-positioning.

This study explores the capability of the COMPASS system (IBA Dosimetry, Germany) to detect leaf positioning errors of a high resolution MLC with 4mm leaf width using a lower resolution (7.62mm detector spacing) 2D matrix of ionisation chambers